<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychol Med</journal-id><journal-id journal-id-type="iso-abbrev">Psychol Med</journal-id><journal-id journal-id-type="publisher-id">PSM</journal-id><journal-title-group><journal-title>Psychological Medicine</journal-title></journal-title-group><issn pub-type="ppub">0033-2917</issn><issn pub-type="epub">1469-8978</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40357917</article-id><article-id pub-id-type="pmc">PMC12094642</article-id>
<article-id pub-id-type="doi">10.1017/S0033291725001126</article-id><article-id pub-id-type="pii">S0033291725001126</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Brief psychological interventions for schizophrenia: a systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-9453-4788</contrib-id><name><surname>Pike</surname><given-names>Blue</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9450-7210</contrib-id><name><surname>Ambrosio</surname><given-names>Leire</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6051-3604</contrib-id><name><surname>Ellett</surname><given-names>Lyn</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Recovery Service, <institution>Hampshire and Isle of Wight Healthcare NHS Foundation Trust</institution>, <city>Isle of Wight</city>, <country>UK</country></aff><aff id="aff2"><label>2</label>School of Health and Life Sciences, <institution>University of Southampton</institution>, <city>Southampton</city>, <country>UK</country></aff><aff id="aff3"><label>3</label>School of Psychology, <institution>University of Southampton</institution>, <city>Southampton</city>, <country>UK</country></aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Blue Pike; Email: <email>blue.pike@nhs.net</email></corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2025"><year>2025</year></pub-date><pub-date pub-type="epub"><day>13</day><month>5</month><year>2025</year></pub-date><volume>55</volume><elocation-id>e146</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>11</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0033291725001126a.pdf"/><abstract><sec id="sec1"><title>Background</title><p>Although cognitive behavioral therapy for people diagnosed with schizophrenia (CBTp) is recommended in clinical guidelines internationally, rates of implementation are low. One consequence of this has been the development of brief individual psychological interventions, which are shorter than the recommended minimum of 16 sessions for CBTp. This article is the first to systematically identify the brief interventions that exist for people diagnosed with schizophrenia and to determine their effectiveness using meta-analysis.</p></sec><sec id="sec2"><title>Methods</title><p>Five electronic databases (PsycINFO, MEDLINE, CINAHL, EMBASE, and Web of Science) were searched for peer-reviewed randomized controlled trials or experimental studies of brief individual psychological interventions delivered in community settings. Random effects meta-analysis was used to integrate effect sizes, due to the heterogeneity of included studies.</p></sec><sec id="sec3"><title>Results</title><p>Fourteen studies were identified (n&#x000a0;=&#x000a0;1,382) that measured thirty clinical outcomes and included six intervention types - brief CBT, memory training, digital motivation support, reasoning training, psychoeducation, and virtual reality. Collectively, brief psychological interventions were found to be effective for psychotic symptoms (SMD &#x02212;0.285, p&#x000a0;&#x0003c;&#x000a0;0.01), paranoia (SMD &#x02212;0.277, p&#x000a0;&#x0003c;&#x000a0;0.05), data gathering (SMD 0.38, p&#x000a0;&#x0003c;&#x000a0;0.01), depression (SMD &#x02212;0.906, p&#x000a0;&#x0003c;&#x000a0;0.05) and wellbeing (SMD 0.405, p&#x000a0;&#x0003c;&#x000a0;0.01). For intervention types, brief CBT was effective for psychotic symptoms (SMD &#x02212;0.32, p&#x000a0;&#x0003c;&#x000a0;.001), and reasoning training was effective for data gathering (SMD 0.38, p&#x000a0;&#x0003c;&#x000a0;0.01).</p></sec><sec id="sec4"><title>Conclusions</title><p>Overall, the evidence suggests that brief psychological interventions are effective for several key difficulties associated with schizophrenia, providing an opportunity to improve both access to, and choice of, treatment for individuals diagnosed with schizophrenia.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>brief intervention</kwd><kwd>CBT</kwd><kwd>meta-analysis</kwd><kwd>schizophrenia</kwd><kwd>systematic review</kwd></kwd-group><counts><fig-count count="5"/><table-count count="3"/><ref-count count="37"/><page-count count="7"/></counts></article-meta></front><body><sec sec-type="intro" id="sec5"><title>Introduction</title><p>Worldwide, access to effective treatment for schizophrenia is extremely limited, with only 31.3% receiving specialist care for psychosis (WHO, <xref rid="r48" ref-type="bibr">2022</xref>). Cognitive Behavior Therapy for psychosis (CBTp) is one of the first-line treatments for schizophrenia recommended internationally in clinical guidelines, for example, in England and Wales, Germany, Canada, Australia, and New Zealand (Australian, <xref rid="r2" ref-type="bibr">2005</xref>; Dixon et al., <xref rid="r9" ref-type="bibr">2010</xref>; Gaebel, Riesbeck, &#x00026; Wobrock, <xref rid="r17" ref-type="bibr">2011</xref>; NICE, <xref rid="r31" ref-type="bibr">2014</xref>; Norman, Lecomte, Addington, &#x00026; Anderson, <xref rid="r32" ref-type="bibr">2017</xref>). In the UK, NICE (<xref rid="r31" ref-type="bibr">2014</xref>) recommends a minimum of 16 sessions of CBTp (NICE., <xref rid="r31" ref-type="bibr">2014</xref>). A recent review in the Netherlands found implementation rates for CBTp of 19&#x02013;24% with a third of these treatments provided by psychologists who were not trained in CBTp (van de Ven et al., <xref rid="r44" ref-type="bibr">2025</xref>). However, rates of implementation for CBTp are still below recommended levels with wide variation in rates found (Ince, Haddock, &#x00026; Tai, <xref rid="r21" ref-type="bibr">2016</xref>), with a review of international implementation rates for CBTp finding a pooled prevalence rate of 24% (Burgess-Barr et al., <xref rid="r6" ref-type="bibr">2023</xref>).</p><p>There are a number of factors that contribute to poor access to CBTp, including constraints in service delivery due to increasing demand (Cantor, <xref rid="r7" ref-type="bibr">2022</xref>) and a scarcity of trained therapists (O&#x02019;Connor et al., <xref rid="r33" ref-type="bibr">2018</xref>). Beyond the UK, other factors cited include a lack of appropriate health insurance (Chamberlin, <xref rid="r55" ref-type="bibr">2004</xref>) and limited access to health facilities (Dye, Reeder., &#x00026; Terry, <xref rid="r50" ref-type="bibr">2013</xref>). One consequence of this has been the development of more targeted treatments that require fewer sessions, referred to as &#x02018;brief interventions&#x02019; (Sijbrandij, Kleiboer, &#x00026; Farooq, <xref rid="r39" ref-type="bibr">2020</xref>). Brief CBT interventions have been shown to be effective for anxiety and depression (Wakefield et al., <xref rid="r46" ref-type="bibr">2021</xref>) and are recommended by the National Institute for Health and Care Excellence (NICE, <xref rid="r30" ref-type="bibr">2022</xref>), and there is emerging evidence that brief CBT interventions are also effective for people with psychosis (Hazell, Hayward, Cavanagh, &#x00026; Strauss, <xref rid="r19" ref-type="bibr">2016</xref>). Additionally, some studies have found that using more discrete components of CBT has been effective for treating individual psychotic symptoms, including persecutory delusions (Freeman et al., <xref rid="r14" ref-type="bibr">2016</xref>), and auditory hallucinations (Craig et al., <xref rid="r8" ref-type="bibr">2018</xref>).</p><p>A systematic review and meta-analysis of low intensity CBTp of 10 controlled trials with &#x0003c;16 sessions found a small-medium effect (<italic toggle="yes">d</italic>&#x000a0;=&#x000a0;&#x02212;0.46), which was maintained at follow-up (<italic toggle="yes">d</italic>&#x000a0;=&#x000a0;&#x02212;0.40) for symptoms of psychosis (Hazell et al., <xref rid="r19" ref-type="bibr">2016</xref>). The effect sizes found for brief CBTp were similar to those found in meta-analyses of standard CBTp, suggesting that brief interventions are beneficial for people diagnosed with schizophrenia (Hazell et al., <xref rid="r19" ref-type="bibr">2016</xref>). However, this review was limited in its focus to brief CBT interventions only, and there is no current review summarizing the full range of brief interventions available for people diagnosed with schizophrenia. Therefore, the aim of this study was to review the range and effectiveness of brief (&#x0003c;16 sessions) interventions for schizophrenia. The review focuses on community interventions as factors such as acuity and length of admission can impact the type and duration of interventions that are accessible for inpatients (Duncan et al., <xref rid="r10" ref-type="bibr">2021</xref>; Johnson et al., <xref rid="r23" ref-type="bibr">2022</xref>). The review addressed the following research questions: 1. What brief individual psychological interventions exist for people diagnosed with schizophrenia? 2. How effective are brief psychological interventions for reducing psychotic symptoms? 3. How effective are brief psychological interventions for improving secondary outcomes?</p></sec><sec sec-type="methods" id="sec6"><title>Methods</title><sec sec-type="other" id="sec7"><title>Protocol and search strategy</title><p>The protocol for this review was registered with PROSPERO on November 24, 2023 (PROSPERO registration CRD42023479319).</p><p>Five electronic databases were searched in December 2023, including PsycINFO, MEDLINE, CINAHL, EMBASE, and Web of Science. The search terms Schizophrenia* OR Schizophrenia (MeSH term) OR psychosis OR psychoses OR psychotic disorder OR schizophrenic disorder OR hallucination* OR voice* OR auditory hallucination* OR delusion* AND brief intervention* OR short-term were used in abstract and title, and limitations were added for papers that included adults 18+ years, were peer reviewed and published in English language. Search results were exported from each database to Rayyan (<uri xlink:href="https://www.rayyan.ai/">https://www.rayyan.ai/</uri>) where duplicate records were removed.</p></sec><sec sec-type="other" id="sec8"><title>Inclusion and exclusion criteria</title><p>Inclusion criteria: (1) randomized controlled trials (RCT) or randomized experimental studies, (2) studies that include populations of individuals with a schizophrenia spectrum diagnosis, (3) community treatment, and (4) individual interventions with a duration of less than 16 sessions.</p><p>Exclusion criteria: (1) study focus is medication (2) focus is on caregivers or staff, (3) qualitative study or case study, (4) focus is on drug, smoking or alcohol use, (5) focus is on inpatient care (including forensic setting) or transfer to community, (6) book chapters/editorials and existing reviews, (7) secondary analysis of already published datasets, and (8) group interventions.</p></sec><sec sec-type="other" id="sec9"><title>Study selection</title><p>PRISMA guidelines informed the search strategy (Page et al., <xref rid="r34" ref-type="bibr">2021</xref>, see <xref rid="fig1" ref-type="fig">Figure 1</xref>). Backwards citation searches were completed for included studies, and further potential studies were assessed against the same inclusion and exclusion criteria, which did not result in any further studies being included in the review. An independent reviewer screened 10% of the search results, and any differences were resolved by discussion.</p></sec><sec sec-type="other" id="sec10"><title>Data extraction</title><p>The main characteristics of each study were extracted and tabulated (see Supplementary <uri xlink:href="http://doi.org/10.1017/S0033291725001126">Table&#x000a0;1</uri>). Three studies did not report effect sizes in their results. For independent samples of equal size, missing effect sizes were calculated using post-intervention means and standard deviation (SD) (Soper, <xref rid="r40" ref-type="bibr">2024</xref>). When post manipulation means or SD were missing, this was requested by contacting the study authors.</p></sec><sec sec-type="other" id="sec11"><title>Risk of bias assessment</title><p>Each study was assessed using the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2), which includes 28 questions over 5 different domains (Sterne <italic toggle="yes">et al</italic>., <xref rid="r900" ref-type="bibr">2019</xref>). The score range includes: low risk of bias; some concerns &#x02013; where there are some concerns in at least one domain, but no domain with a high risk of bias; and high risk of bias &#x02013; where there is a high risk of bias in at least one domain, or the study is judged to have some concerns for multiple domains in a way that substantially lowers confidence in the result.</p><p>Thirteen studies scored low risk of bias and one scored some concerns. An independent reviewer repeated the RoB assessment for all fourteen studies. This resulted in agreement in the overall risk of bias rating for each study, which is reported in Supplementary <uri xlink:href="http://doi.org/10.1017/S0033291725001126">Table&#x000a0;1</uri>.</p></sec><sec sec-type="other" id="sec12"><title>Statistical analysis</title><p>Statistical software MedCalc (<uri xlink:href="https://www.medcalc.org/">https://www.medcalc.org/</uri>) was used to conduct all statistical analyses. A random effects meta-analysis was used to integrate effect sizes, due to the heterogeneity of included studies. Statistical heterogeneity was examined and quantified using the <italic toggle="yes">Q</italic> test and <italic toggle="yes">I</italic>
<sup>2</sup> statistic, with high heterogeneity indicated by a significant <italic toggle="yes">Q</italic> test result (&#x0003c;0.05) or an <italic toggle="yes">I</italic>
<sup>2</sup> score of over 50%. Publication bias was assessed through visual examination of funnel plots and the results of Egger&#x02019;s test, with results falling outside of the funnel plot or a significant Egger&#x02019;s result (&#x0003c;0.05) indicating the presence of publication bias.</p></sec></sec><sec sec-type="results" id="sec13"><title>Results</title><sec sec-type="other" id="sec14"><title>Summary of studies</title><p>Fourteen studies met criteria for inclusion in the review (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;1,382), of which nine were randomized controlled trials (RCT) (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;666), two were pragmatic randomized controlled trials (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;523), one used a Solomon four-group design using randomization (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;80), one was a randomized experimental investigation (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;34), and one was a feasibility RCT (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;79). Twelve studies used a control group of treatment as usual (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;1,223), and two studies used an active control, one of supportive counselling and one with a relaxation intervention (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;159). Six intervention types were used across studies: (1) brief CBT (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;6), (2) memory training (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;2), (3) digital motivation support (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;2), (4) reasoning training module (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;2), (5) psychoeducation (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), and (6) virtual reality (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1). Nine studies used face-to-face interventions, and five used other methods, including 8&#x000a0;weeks of text messages following a single face-to-face session, using an app with an assigned motivation coach for 12&#x000a0;weeks, accessing a single brief computerized reasoning training module, and using virtual reality.</p></sec><sec sec-type="other" id="sec15"><title>Summary of effect sizes</title><p>In total, 30 clinical outcomes were measured across the 14 studies (see <xref rid="tab1" ref-type="table">Table 1</xref> for a summary of effect sizes). Large effect sizes were reported for insomnia (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1); medium to large effect sizes were reported for psychological recovery (CHOICE) (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;3); small to large effect sizes were reported for psychotic symptoms (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;8); medium effect sizes were reported for social comparison (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), self-concept (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), defeatist beliefs (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), self-efficacy (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1); small to medium effect sizes were reported for depression (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;6), delusions (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;5), paranoia (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;5), quality of life (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;3), motivation (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;2), negative symptoms (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1); small effect sizes were reported for wellbeing (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;5), anxiety (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;3), functioning (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;2), data gathering (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;2), self-esteem (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), subjective goal attainment (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), future reward-value representations (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), effort-cost computations (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), neurocognition (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), worry (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), rumination (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), negative beliefs about self (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), suicidal ideation (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1); and effect sizes were not reported for insight, hospitalization (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), social functioning (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1), self-stigma (<italic toggle="yes">k</italic>&#x000a0;=&#x000a0;1). Findings from individual studies, including outcome measures used, are listed in Supplementary <uri xlink:href="http://doi.org/10.1017/S0033291725001126">Table&#x000a0;1</uri>.<fig position="float" id="fig1"><label>Figure 1.</label><caption><p>PRISMA flowchart of search results.</p></caption><graphic xlink:href="S0033291725001126_fig1" position="float"/></fig>
<table-wrap position="float" id="tab1"><label>Table 1.</label><caption><p>Summary of effect sizes for clinical outcomes</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Outcome (number of studies)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Effect size range</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Psychotic symptoms (9)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.02, 0.91</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Depression (6)</td><td align="center" valign="top" rowspan="1" colspan="1">0.43, 0.68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Delusions (4)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.1, 0.49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Well-being (4)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.13, 1.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Paranoia (4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.01, 0.59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anxiety (3)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.21, 0.28</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Quality of life (3)</td><td align="center" valign="top" rowspan="1" colspan="1">0, 0.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Psychological recovery (CHOICE) (3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.5, 0.87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functioning (2)</td><td align="center" valign="top" rowspan="1" colspan="1">0.09, &#x02212;0.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Motivation (2)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.14, 0.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Insight (2)</td><td align="center" valign="top" rowspan="1" colspan="1">not reported</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Data gathering (2)</td><td align="center" valign="top" rowspan="1" colspan="1">0.21, 0.41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-esteem (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Subjective goal attainment (1)</td><td align="center" valign="top" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Future reward-value representations (1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.27</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Effort-cost computations (1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.11</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Negative symptoms (1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.14, &#x02212;0.66</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neurocognition (1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hospitalization (1)</td><td align="center" valign="top" rowspan="1" colspan="1">Data not reported</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Social functioning (1)</td><td align="center" valign="top" rowspan="1" colspan="1">Data not reported</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Worry (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rumination (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-stigma (1)</td><td align="center" valign="top" rowspan="1" colspan="1">Data not reported</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Negative beliefs about self (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Social comparison (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-concept (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Insomnia (1)</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Defeatist beliefs (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-efficacy (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Suicidal ideation (1)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr></tbody></table><graphic xlink:href="S0033291725001126_tab1" position="float"/></alternatives></table-wrap></p></sec></sec><sec sec-type="other" id="sec16"><title>Meta-analysis findings</title><p>Meta-analysis was used to assess the effectiveness of brief interventions by clinical outcome (<xref rid="tab2" ref-type="table">Table 2</xref>), and by intervention type (<xref rid="tab3" ref-type="table">Table 3</xref>). Please see <xref rid="fig2" ref-type="fig">Figures 2</xref>&#x02013;<xref rid="fig5" ref-type="fig">5</xref> for the forest plots for each analysis. A separate analysis was conducted for studies using active controls. Meta-analysis was conducted where at least two studies reported the required data (Valentine, Pigott, &#x00026; Rothstein, <xref rid="r43" ref-type="bibr">2010</xref>). Inspection of funnel plots and the results of Egger&#x02019;s test identified four analyses showing publication bias, these were for self-esteem, functioning, quality of life, and memory training for depression. Trim and Fill analyses were not undertaken, given only two studies were reported for each of these outcomes and trim and fill is recommended only when at least 10 studies are reported (Mavridis &#x00026; Salanti, <xref rid="r28" ref-type="bibr">2014</xref>).<fig position="float" id="fig2"><label>Figure 2.</label><caption><p>Forest plot for Psychotic Symptoms.</p></caption><graphic xlink:href="S0033291725001126_fig2" position="float"/></fig>
<table-wrap position="float" id="tab2"><label>Table 2.</label><caption><p>Meta-analysis results by clinical outcome</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Clinical outcome</th><th align="center" valign="bottom" rowspan="1" colspan="1">SMD</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">t</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">P</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Q</italic> test</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">I</italic>
<sup>2</sup></th><th align="center" valign="bottom" rowspan="1" colspan="1">Eggers test</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Depression</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.906</td><td align="center" valign="top" rowspan="1" colspan="1">0.408</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.711, &#x02212;0.102</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.219</td><td align="center" valign="top" rowspan="1" colspan="1">0.027</td><td align="center" valign="top" rowspan="1" colspan="1">25.9309**</td><td align="center" valign="top" rowspan="1" colspan="1">88.43%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;4.4207</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-esteem</td><td align="center" valign="top" rowspan="1" colspan="1">0.169</td><td align="center" valign="top" rowspan="1" colspan="1">0.477</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.775, 1.114</td><td align="center" valign="top" rowspan="1" colspan="1">0.355</td><td align="center" valign="top" rowspan="1" colspan="1">0.723</td><td align="center" valign="top" rowspan="1" colspan="1">5.2879*</td><td align="center" valign="top" rowspan="1" colspan="1">81.09%</td><td align="center" valign="top" rowspan="1" colspan="1">5.7396**</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Psychotic symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.285</td><td align="center" valign="top" rowspan="1" colspan="1">0.09</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.462, &#x02212;0.108</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.166</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">1.4704</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.2751</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Data gathering</td><td align="center" valign="top" rowspan="1" colspan="1">0.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.121</td><td align="center" valign="top" rowspan="1" colspan="1">0.141, 0.619</td><td align="center" valign="top" rowspan="1" colspan="1">3.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.8558</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.7373</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anxiety</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.157</td><td align="center" valign="top" rowspan="1" colspan="1">0.202</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.555, 0.241</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.777</td><td align="center" valign="top" rowspan="1" colspan="1">0.438</td><td align="center" valign="top" rowspan="1" colspan="1">3.2245</td><td align="center" valign="top" rowspan="1" colspan="1">37.97%</td><td align="center" valign="top" rowspan="1" colspan="1">3.5798</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Functioning</td><td align="center" valign="top" rowspan="1" colspan="1">0.201</td><td align="center" valign="top" rowspan="1" colspan="1">0.159</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.113, 0.516</td><td align="center" valign="top" rowspan="1" colspan="1">1.266</td><td align="center" valign="top" rowspan="1" colspan="1">0.208</td><td align="center" valign="top" rowspan="1" colspan="1">0.3071</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.8454**</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Delusions</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.146</td><td align="center" valign="top" rowspan="1" colspan="1">0.132</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.407, 0.114</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.106</td><td align="center" valign="top" rowspan="1" colspan="1">0.269</td><td align="center" valign="top" rowspan="1" colspan="1">4.0008</td><td align="center" valign="top" rowspan="1" colspan="1">25.01%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03029</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Paranoia</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.277</td><td align="center" valign="top" rowspan="1" colspan="1">0.11</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.492, &#x02212;0.0612</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.526</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td align="center" valign="top" rowspan="1" colspan="1">0.7779</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">1.2344</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Wellbeing</td><td align="center" valign="top" rowspan="1" colspan="1">0.405</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.130, 0.680</td><td align="center" valign="top" rowspan="1" colspan="1">2.898</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td><td align="center" valign="top" rowspan="1" colspan="1">4.3019</td><td align="center" valign="top" rowspan="1" colspan="1">30.26%</td><td align="center" valign="top" rowspan="1" colspan="1">1.3716</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Quality of life</td><td align="center" valign="top" rowspan="1" colspan="1">0.157</td><td align="center" valign="top" rowspan="1" colspan="1">0.192</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.224, 0.538</td><td align="center" valign="top" rowspan="1" colspan="1">0.818</td><td align="center" valign="top" rowspan="1" colspan="1">0.415</td><td align="center" valign="top" rowspan="1" colspan="1">0.7581</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">19.8017**</td></tr><tr><td align="left" colspan="9" valign="top" rowspan="1">Active control</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Psychotic symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.077</td><td align="center" valign="top" rowspan="1" colspan="1">0.153</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.380, 0.226</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.503</td><td align="center" valign="top" rowspan="1" colspan="1">0.601</td><td align="center" valign="top" rowspan="1" colspan="1">0.6072</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">3.5636</td></tr></tbody></table><graphic xlink:href="S0033291725001126_tab2" position="float"/></alternatives><table-wrap-foot><p>
<italic toggle="yes">Note:</italic> *p&#x000a0;&#x0003c;&#x000a0;.05, **p&#x000a0;&#x0003c;&#x000a0;.001</p></table-wrap-foot></table-wrap>
<fig position="float" id="fig3"><label>Figure 3.</label><caption><p>Forest plot for paranoia.</p></caption><graphic xlink:href="S0033291725001126_fig3" position="float"/></fig>
<table-wrap position="float" id="tab3"><label>Table 3.</label><caption><p>Meta analysis results by intervention type</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Intervention type and clinical outcome</th><th align="center" valign="bottom" rowspan="1" colspan="1">SMD</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">t</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">P</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Q</italic> test</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">I</italic>
<sup>2</sup></th><th align="center" valign="bottom" rowspan="1" colspan="1">Eggers test</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Brief CBT for psychotic symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.315</td><td align="center" valign="top" rowspan="1" colspan="1">0.117</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.546, &#x02212;0.0850</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.694</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">0.7468</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.08767</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reasoning training for data gathering (delusions)</td><td align="center" valign="top" rowspan="1" colspan="1">0.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.121</td><td align="center" valign="top" rowspan="1" colspan="1">0.141, 0.619</td><td align="center" valign="top" rowspan="1" colspan="1">3.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.8558</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.7373</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Memory training for depression</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.16</td><td align="center" valign="top" rowspan="1" colspan="1">0.848</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.834, 0.515</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.367</td><td align="center" valign="top" rowspan="1" colspan="1">0.173</td><td align="center" valign="top" rowspan="1" colspan="1">24.5469**</td><td align="center" valign="top" rowspan="1" colspan="1">95.93%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;21.6467**</td></tr></tbody></table><graphic xlink:href="S0033291725001126_tab3" position="float"/></alternatives><table-wrap-foot><p>
<italic toggle="yes">Note:</italic> **p&#x000a0;&#x0003c;&#x000a0;.0001</p></table-wrap-foot></table-wrap></p><sec sec-type="other" id="sec17"><title>Brief interventions by clinical outcome</title><p>
<xref rid="tab2" ref-type="table">Table 2</xref> shows the results from the meta-analyses of the cumulative effect of brief interventions by clinical outcome. Compared with treatment as usual, brief interventions were effective for psychotic symptoms, data gathering, paranoia, well-being, and depression. Brief interventions were not effective for self-esteem, anxiety, delusions, or quality of life. Compared with active control conditions, brief interventions did not appear to be effective for psychotic symptoms, though caution is needed in interpreting this finding given the very small number of studies that have used an active control.<fig position="float" id="fig4"><label>Figure 4.</label><caption><p>Forest plot for depression.</p></caption><graphic xlink:href="S0033291725001126_fig4" position="float"/></fig></p></sec><sec sec-type="other" id="sec18"><title>Brief interventions by intervention type</title><p>
<xref rid="tab3" ref-type="table">Table 3</xref> shows the results from the meta-analyses by intervention type. Brief CBT for psychotic symptoms was effective, reasoning training for data gathering was effective, and memory training for depression was not effective.<fig position="float" id="fig5"><label>Figure 5.</label><caption><p>Forest plot for Well-Being.</p></caption><graphic xlink:href="S0033291725001126_fig5" position="float"/></fig></p></sec></sec><sec sec-type="discussion" id="sec19"><title>Discussion</title><p>This study is the first to systematically identify the brief (&#x0003c;16 sessions) psychological interventions that exist for people diagnosed with schizophrenia and to determine their effectiveness using meta-analysis. The review identified fourteen studies, of which 12 compared the brief intervention to treatment as usual and two used an active control. Thirty clinical outcomes were reported on across studies, and six different types of brief intervention were identified, which included brief CBT, memory training, digital motivation support, reasoning training, psychoeducation, and virtual reality. The findings by clinical outcome suggest that brief interventions are effective for psychotic symptoms, paranoia, depression, data-gathering, and well-being. There was no evidence that brief interventions were effective in relation to self-esteem, anxiety, delusions, and quality of life in individuals with schizophrenia. There was no evidence that brief interventions were more effective for psychotic symptoms when compared with active controls, though it is too early to draw any definitive conclusions with only two studies published to date. Meta-analyses by intervention type showed that brief CBT was effective for psychotic symptoms, and reasoning training was effective for data gathering, with no evidence for the effectiveness of memory training for depression. Overall, the evidence in relation to the use of brief interventions for people diagnosed with schizophrenia is encouraging, but caution is warranted in the interpretation of findings from the review given the small number of studies published to date.</p><p>The review found small to medium effect sizes for brief CBTp, which supports the findings of Hazell et al. (<xref rid="r19" ref-type="bibr">2016</xref>) and is similar to those found for standard CBTp (Jauhar et al., <xref rid="r22" ref-type="bibr">2014</xref>). The findings of this review add to the literature by showing that other types of brief psychological interventions beyond CBT might also be helpful for people diagnosed with schizophrenia. Shorter treatments may be more acceptable for individuals who do not want or who are not ready to engage in longer and/or more intensive therapy (Blenkiron, <xref rid="r5" ref-type="bibr">1999</xref>). Brief interventions also have the potential to result in cost reductions via reduced therapist time, though this would need to be established in future research. Also noteworthy is that two studies included in this review used brief CBT delivered by assistant psychologists (Hayward <italic toggle="yes">et al.</italic>, <xref rid="r56" ref-type="bibr">2021</xref>) and community psychiatric nurses (Turkington, Kingdon &#x00026; Turner, <xref rid="r52" ref-type="bibr">2002</xref>), and both provided evidence for effectiveness. This suggests that training other professionals to deliver brief CBT to target discreet problems related to schizophrenia could improve accessibility to psychological treatments for this clinical group. The interventions included in this review ranged from a single session to twelve sessions, with two having a single session supported by digital contact (Luther et al., <xref rid="r53" ref-type="bibr">2020</xref>; Schlosser et al., <xref rid="r54" ref-type="bibr">2018</xref>). As with intervention type and target problem, delivery mode and length also need to align with patient preferences, with interventions of shorter duration being selected to suit patient needs (for example cognitive impairment affecting memory and attention), and clinical indication (i.e. a discreet issue where there is an evidence base for the efficacy of the intervention). Furthermore, patient preferences for therapy targets need to be considered, as these may differ from clinician priorities (Loizou, Fowler, &#x00026; Hayward, <xref rid="r27" ref-type="bibr">2024</xref>).</p><p>There are several limitations of the review. Three studies did not provide adequate data to be included in meta-analyses, and whilst study authors were contacted to seek this, data were not provided. Caution is warranted in the interpretation of findings from the review, given the small number of studies included in the meta-analyses (Myung, <xref rid="r29" ref-type="bibr">2023</xref>) and the degree of heterogeneity evident. The studies included in the review were predominantly randomized controlled trials, and it is not clear whether the findings will generalize to routine clinical practice. The effectiveness of other approaches that did not fit the remit for this review, such as Hearing Voices Groups, was not considered. Additionally, the majority of studies used treatment as usual as the control condition, making it difficult to separate the effects of intervention versus nonspecific therapy effects.</p><p>The review highlights a number of areas for future research. Although the evidence base for brief interventions is promising, more studies are needed to be able to draw definitive conclusions regarding their effectiveness and potential cost-effectiveness. Future studies also need to determine mediators and moderators of brief interventions to determine which types of interventions work best for different groups, including individuals from diverse and underserved communities. Additionally, qualitative research could explore service users&#x02019; experience of brief interventions. The effectiveness of brief interventions available for inpatients with psychosis also warrants attention.</p><p>Overall, the evidence to date suggests that brief interventions are effective for reducing psychotic symptoms, paranoia, and depression, and improving well-being in individuals with schizophrenia. In relation to intervention types, brief CBT was effective for psychotic symptoms, and reasoning training was effective for data gathering. Overall, the evidence suggests that brief psychological interventions are effective for several key difficulties associated with schizophrenia, providing an opportunity to improve both access to, and choice of, treatment for individuals with schizophrenia.</p></sec><sec sec-type="supplementary-material" id="sec22"><title>Supporting information</title><supplementary-material id="sm01" position="float" content-type="local-data"><caption><title>Pike et al. supplementary material</title><p>Pike et al. supplementary material</p></caption><media xlink:href="S0033291725001126sup001.docx" id="d67e1126" position="anchor"/></supplementary-material></sec></body><back><sec sec-type="supplementary-material" id="nts1"><title>Supplementary material</title><p>The supplementary material for this article can be found at <uri xlink:href="http://doi.org/10.1017/S0033291725001126">http://doi.org/10.1017/S0033291725001126</uri>.</p></sec><sec sec-type="funding-statement" id="sec20"><title>Funding statement</title><p>This work was supported by an NIHR ARC Wessex/CRN Research Initiation Internship Award.</p></sec><sec sec-type="COI-statement" id="sec21"><title>Competing interests</title><p>The authors Blue Pike, Leire Ambrosio and Lyn Ellett declare none.</p></sec><ref-list id="refs1" content-type="normal"><title>References</title><ref id="r2"><mixed-citation publication-type="journal" id="ref2"><string-name><surname>Australian</surname>, <given-names>R.</given-names></string-name> (<year>2005</year>). <article-title>Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders</article-title>. <source>Australian &#x00026; New Zealand Journal of Psychiatry</source>, <volume>39</volume>, <fpage>1</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">15660702</pub-id>
</mixed-citation></ref><ref id="r5"><mixed-citation publication-type="journal" id="ref5"><string-name><surname>Blenkiron</surname>, <given-names>P.</given-names></string-name> (<year>1999</year>). <article-title>Who is suitable for cognitive behavioural therapy?</article-title>
<source>Journal of the Royal Society of Medicine</source>, <volume>92</volume>(<issue>5</issue>), <fpage>222</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">10472256</pub-id>
</mixed-citation></ref><ref id="r6"><mixed-citation publication-type="journal" id="ref6"><string-name><surname>Burgess-Barr</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nicholas</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Venus</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Singh</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Nethercott</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Taylor</surname>, <given-names>G.</given-names></string-name>, &#x00026; <string-name><surname>Jacobsen</surname>, <given-names>P.</given-names></string-name> (<year>2023</year>). <article-title>International rates of receipt of psychological therapy for psychosis and schizophrenia: Systematic review and meta-analysis</article-title>. <source>International Journal of Mental Health Systems</source>, <volume>17</volume>(<issue>1</issue>), <fpage>8</fpage>.<pub-id pub-id-type="pmid">37004066</pub-id>
</mixed-citation></ref><ref id="r7"><mixed-citation publication-type="other" id="ref7"><string-name><surname>Cantor</surname>, <given-names>M.</given-names></string-name> (<year>2022</year>). <italic toggle="yes">&#x02018;We&#x02019;re in a trauma together&#x02019;: Americans need therapy &#x02013; but psychologists are booked.</italic> Retrieved from: Mental health | The Guardian.</mixed-citation></ref><ref id="r55"><mixed-citation publication-type="journal" id="ref55"><string-name><surname>Chamberlin</surname>, <given-names>J.</given-names></string-name> (<year>2004</year>). <article-title>Survey says: More Americans are seeking mental health treatment</article-title>. <source>Monitor on Psychology</source>, <volume>35</volume>(<issue>7</issue>), <fpage>17</fpage>.</mixed-citation></ref><ref id="r8"><mixed-citation publication-type="journal" id="ref8"><string-name><surname>Craig</surname>, <given-names>T. K.</given-names></string-name>, <string-name><surname>Rus-Calafell</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ward</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Leff</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Huckvale</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Howarth</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Emsley</surname>, <given-names>R.</given-names></string-name> &#x00026; <string-name><surname>Garety</surname>, <given-names>P. A.</given-names></string-name> (<year>2018</year>). <article-title>AVATAR therapy for auditory verbal hallucinations in people with psychosis: A single-blind, randomised controlled trial</article-title>. <source>Lancet Psychiatry</source>, <volume>5</volume>(<issue>1</issue>), <fpage>31</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">29175276</pub-id>
</mixed-citation></ref><ref id="r9"><mixed-citation publication-type="journal" id="ref9"><string-name><surname>Dixon</surname>, <given-names>L. B.</given-names></string-name>, <string-name><surname>Dickerson</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Bellack</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dickinson</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Goldberg</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Lehman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tenhula</surname>, <given-names>W.N.</given-names></string-name>, <string-name><surname>Calmes</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Pasillas</surname>, <given-names>R.M.</given-names></string-name> and <string-name><surname>Peer</surname>, <given-names>J.</given-names></string-name> (<year>2010</year>). <article-title>The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements</article-title>. <source>Schizophrenia Bulletin</source>, <volume>36</volume>(<issue>1</issue>), <fpage>48</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">19955389</pub-id>
</mixed-citation></ref><ref id="r10"><mixed-citation publication-type="journal" id="ref10"><string-name><surname>Duncan</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Baskin</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>McGrath</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Coker</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Dykxhoorn</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Adams</surname>, <given-names>E.A.</given-names></string-name>, <string-name><surname>Gnani</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lafortune</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Kirkbride</surname>, <given-names>J.B.</given-names></string-name> &#x00026; <string-name><surname>Kaner</surname>, <given-names>E.</given-names></string-name> (<year>2021</year>). <article-title>Community interventions for improving adult mental health: Mapping local policy and practice in England</article-title>. <source>BMC Public Health</source>, <volume>21</volume>, <fpage>1</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">33388037</pub-id>
</mixed-citation></ref><ref id="r50"><mixed-citation publication-type="journal" id="ref50"><string-name><surname>Dye</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Reeder</surname>, <given-names>J. C.</given-names></string-name>, &#x00026; <string-name><surname>Terry</surname>, <given-names>R. F.</given-names></string-name> (<year>2013</year>). <article-title>Research for universal health coverage</article-title>. <source>Science translational medicine</source>, <volume>5</volume>(<issue>199</issue>), <fpage>199ed13</fpage>&#x02013;<lpage>199ed13</lpage>.</mixed-citation></ref><ref id="r14"><mixed-citation publication-type="journal" id="ref14"><string-name><surname>Freeman</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bradley</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Antley</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bourke</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>DeWeever</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>&#x0010c;ernis</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Sheaves</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Waite</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Dunn</surname>, <given-names>G.</given-names></string-name> &#x00026; <string-name><surname>Slater</surname>, <given-names>M.</given-names></string-name> (<year>2016</year>). <article-title>Virtual reality in the treatment of persecutory delusions: Randomised controlled experimental study testing how to reduce delusional conviction</article-title>. <source>The British Journal of Psychiatry</source>, <volume>209</volume>(<issue>1</issue>), <fpage>62</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">27151071</pub-id>
</mixed-citation></ref><ref id="r15"><mixed-citation publication-type="journal" id="ref15"><string-name><surname>Freeman</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Dunn</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Startup</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Pugh</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Cordwell</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mander</surname>, <given-names>H.</given-names></string-name>, &#x02026; &#x00026; <string-name><surname>Kingdon</surname>, <given-names>D.</given-names></string-name> (<year>2015</year>). <article-title>Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): A parallel, single-blind, randomised controlled trial with a mediation analysis</article-title>. <source>Lancet Psychiatry</source>, <volume>2</volume>(<issue>4</issue>), <fpage>305</fpage>&#x02013;<lpage>313</lpage>.<pub-id pub-id-type="pmid">26360083</pub-id>
</mixed-citation></ref><ref id="r17"><mixed-citation publication-type="journal" id="ref17"><string-name><surname>Gaebel</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Riesbeck</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Wobrock</surname>, <given-names>T.</given-names></string-name> (<year>2011</year>). <article-title>Schizophrenia guidelines across the world: A selective review and comparison</article-title>. <source>International Review of Psychiatry</source>, <volume>23</volume>(<issue>4</issue>), <fpage>379</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="pmid">22026495</pub-id>
</mixed-citation></ref><ref id="r19"><mixed-citation publication-type="journal" id="ref19"><string-name><surname>Hazell</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Hayward</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cavanagh</surname>, <given-names>K.</given-names></string-name>, &#x00026; <string-name><surname>Strauss</surname>, <given-names>C.</given-names></string-name> (<year>2016</year>). <article-title>A systematic review and meta-analysis of low intensity CBT for psychosis</article-title>. <source>Clinical Psychology Review</source>, <volume>45</volume>, <fpage>183</fpage>&#x02013;<lpage>192</lpage>.<pub-id pub-id-type="pmid">27048980</pub-id>
</mixed-citation></ref><ref id="r56"><mixed-citation publication-type="journal" id="ref56"><string-name><surname>Hayward</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Berry</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bremner</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Robertson</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cavanagh</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gage</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Berry</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Neumann</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hazell</surname>, <given-names>C.M.</given-names></string-name> &#x00026; <string-name><surname>Fowler</surname>, <given-names>D.</given-names></string-name>, <year>2021</year>. <article-title>Increasing access to cognitive&#x02013;behavioural therapy for patients with psychosis by evaluating the feasibility of a randomised controlled trial of brief, targeted cognitive&#x02013;behavioural therapy for distressing voices delivered by assistant PSYCHOLOGISTS: the GiVE2 trial</article-title>. <source>BJPsych Open</source>, <volume>7</volume>(<issue>5</issue>), p.<fpage>e152</fpage>.</mixed-citation></ref><ref id="r21"><mixed-citation publication-type="journal" id="ref21"><string-name><surname>Ince</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Haddock</surname>, <given-names>G.</given-names></string-name>, &#x00026; <string-name><surname>Tai</surname>, <given-names>S.</given-names></string-name> (<year>2016</year>). <article-title>A systematic review of the implementation of recommended psychological interventions for schizophrenia: Rates, barriers, and improvement strategies</article-title>. <source>Psychology and Psychotherapy: Theory, Research and Practice</source>, <volume>89</volume>(<issue>3</issue>), <fpage>324</fpage>&#x02013;<lpage>350</lpage>.</mixed-citation></ref><ref id="r22"><mixed-citation publication-type="journal" id="ref22"><string-name><surname>Jauhar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>McKenna</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Radua</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fung</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Salvador</surname>, <given-names>R.</given-names></string-name>, &#x00026; <string-name><surname>Laws</surname>, <given-names>K. R.</given-names></string-name> (<year>2014</year>). <article-title>Cognitive&#x02013;behavioural therapy for the symptoms of schizophrenia: Systematic review and meta-analysis with examination of potential bias</article-title>. <source>British Journal of Psychiatry</source>, <volume>204</volume>(<issue>1</issue>), <fpage>20</fpage>&#x02013;<lpage>29</lpage>.</mixed-citation></ref><ref id="r23"><mixed-citation publication-type="journal" id="ref23"><string-name><surname>Johnson</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Dalton-Locke</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Baker</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hanlon</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Salisbury</surname>, <given-names>T. T.</given-names></string-name>, <string-name><surname>Fossey</surname>, <given-names>M.</given-names></string-name>, &#x02026; &#x00026; <string-name><surname>Lloyd-Evans</surname>, <given-names>B.</given-names></string-name> (<year>2022</year>). <article-title>Acute psychiatric care: Approaches to increasing the range of services and improving access and quality of care</article-title>. <source>World Psychiatry</source>, <volume>21</volume>(<issue>2</issue>), <fpage>220</fpage>&#x02013;<lpage>236</lpage>.<pub-id pub-id-type="pmid">35524608</pub-id>
</mixed-citation></ref><ref id="r26"><mixed-citation publication-type="journal" id="ref26"><string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Gillespie</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>R.</given-names></string-name>, &#x00026; <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name> (<year>2019</year>). <article-title>Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study</article-title>. <source>Psychiatry Research</source>, <volume>272</volume>, <fpage>275</fpage>&#x02013;<lpage>283</lpage>.<pub-id pub-id-type="pmid">30594760</pub-id>
</mixed-citation></ref><ref id="r27"><mixed-citation publication-type="journal" id="ref27"><string-name><surname>Loizou</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fowler</surname>, <given-names>D.</given-names></string-name>, &#x00026; <string-name><surname>Hayward</surname>, <given-names>M.</given-names></string-name> (<year>2024</year>). <article-title>Exploring service users&#x02019; and practitioners&#x02019; priorities regarding outcomes of cognitive behavioural therapy for distressing voices: A thematic analysis</article-title>. <source>Psychosis</source>, <volume>16</volume>(<issue>4</issue>), <fpage>339</fpage>&#x02013;<lpage>351</lpage>.</mixed-citation></ref><ref id="r53"><mixed-citation publication-type="journal" id="ref53"><string-name><surname>Luther</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Fischer</surname>, <given-names>M.W.</given-names></string-name>, <string-name><surname>Johnson-Kwochka</surname>, <given-names>A.V.</given-names></string-name>, <string-name><surname>Minor</surname>, <given-names>K.S.</given-names></string-name>, <string-name><surname>Holden</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lapish</surname>, <given-names>C.L.</given-names></string-name>, <string-name><surname>McCormick</surname>, <given-names>B.</given-names></string-name> &#x00026; <string-name><surname>Salyers</surname>, <given-names>M.P.</given-names></string-name>, <year>2020</year>. <article-title>Mobile enhancement of motivation in schizophrenia: A pilot randomized controlled trial of a personalized text message intervention for motivation deficits</article-title>. <source>Journal of consulting and clinical psychology</source>, <volume>88</volume>(<issue>10</issue>), p.<fpage>923</fpage>.<pub-id pub-id-type="pmid">32790451</pub-id>
</mixed-citation></ref><ref id="r28"><mixed-citation publication-type="journal" id="ref28"><string-name><surname>Mavridis</surname>, <given-names>D.</given-names></string-name>, &#x00026; <string-name><surname>Salanti</surname>, <given-names>G.</given-names></string-name> (<year>2014</year>). <article-title>Exploring and accounting for publication bias in mental health: A brief overview of methods</article-title>. <source>BMJ Mental Health</source>, <volume>17</volume>(<issue>1</issue>), <fpage>11</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="r29"><mixed-citation publication-type="journal" id="ref29"><string-name><surname>Myung</surname>, <given-names>S. K.</given-names></string-name> (<year>2023</year>). <article-title>How to review and assess a systematic review and meta-analysis article: A methodological study (secondary publication)</article-title>. <source>Journal of Educational Evaluation for Health Professions</source>, <volume>20</volume>, <fpage>24</fpage>.<pub-id pub-id-type="pmid">37619974</pub-id>
</mixed-citation></ref><ref id="r30"><mixed-citation publication-type="book" id="ref30"><collab>National Institute for Health and Care Excellence (NICE), (Great Britain)</collab>. (<year>2022</year>). <source>Depression in adults: Treatment and management</source>. <publisher-name>National Institute for Health and Care Excellence (NICE)</publisher-name>.</mixed-citation></ref><ref id="r31"><mixed-citation publication-type="book" id="ref31"><collab>NICE</collab>. (<year>2014</year>). <source>Psychosis and schizophrenia in adults: Prevention and management</source>. <publisher-name>NICE</publisher-name>.</mixed-citation></ref><ref id="r32"><mixed-citation publication-type="journal" id="ref32"><string-name><surname>Norman</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lecomte</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Addington</surname>, <given-names>D.</given-names></string-name>, &#x00026; <string-name><surname>Anderson</surname>, <given-names>E.</given-names></string-name> (<year>2017</year>). <article-title>Canadian treatment guidelines on psychosocial treatment of schizophrenia in adults</article-title>. <source>Canadian Journal of Psychiatry</source>, <volume>62</volume>(<issue>9</issue>), <fpage>617</fpage>&#x02013;<lpage>623</lpage>.<pub-id pub-id-type="pmid">28703017</pub-id>
</mixed-citation></ref><ref id="r33"><mixed-citation publication-type="journal" id="ref33"><string-name><surname>O&#x02019;Connor</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Morgan</surname>, <given-names>K. E.</given-names></string-name>, <string-name><surname>Bailey-Straebler</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fairburn</surname>, <given-names>C. G.</given-names></string-name>, &#x00026; <string-name><surname>Cooper</surname>, <given-names>Z.</given-names></string-name> (<year>2018</year>). <article-title>Increasing the availability of psychological treatments: A multinational study of a scalable method for training therapists</article-title>. <source>Journal of Medical Internet Research</source>, <volume>20</volume>(<issue>6</issue>), <fpage>e10386</fpage>.<pub-id pub-id-type="pmid">29884606</pub-id>
</mixed-citation></ref><ref id="r34"><mixed-citation publication-type="journal" id="ref34"><string-name><surname>Page</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>McKenzie</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Bossuyt</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Boutron</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hoffmann</surname>, <given-names>T. C.</given-names></string-name>, <string-name><surname>Mulrow</surname>, <given-names>C. D.</given-names></string-name>, &#x02026; &#x00026; <string-name><surname>Moher</surname>, <given-names>D.</given-names></string-name> (<year>2021</year>). <article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title>. <source>BMJ</source>, <volume>372</volume>, <fpage>n71</fpage>.<pub-id pub-id-type="pmid">33782057</pub-id>
</mixed-citation></ref><ref id="r54"><mixed-citation publication-type="journal" id="ref54"><string-name><surname>Schlosser</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Campellone</surname>, <given-names>T. R.</given-names></string-name>, <string-name><surname>Truong</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Etter</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Vergani</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Komaiko</surname>, <given-names>K.</given-names></string-name>, &#x00026; <string-name><surname>Vinogradov</surname>, <given-names>S.</given-names></string-name> (<year>2018</year>). <article-title>Efficacy of PRIME, a mobile app intervention designed to improve motivation in young people with schizophrenia</article-title>. <source>Schizophrenia bulletin</source>, <volume>44</volume>(<issue>5</issue>), <fpage>1010</fpage>&#x02013;<lpage>1020</lpage>.<pub-id pub-id-type="pmid">29939367</pub-id>
</mixed-citation></ref><ref id="r39"><mixed-citation publication-type="journal" id="ref39"><string-name><surname>Sijbrandij</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kleiboer</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Farooq</surname>, <given-names>S.</given-names></string-name> (<year>2020</year>). <article-title>low-intensity interventions for psychiatric disorders</article-title>. <source>Frontiers in Psychiatry</source>, <volume>11</volume>, <fpage>619871</fpage>.<pub-id pub-id-type="pmid">33324269</pub-id>
</mixed-citation></ref><ref id="r40"><mixed-citation publication-type="other" id="ref40"><string-name><surname>Soper</surname>, <given-names>D.</given-names></string-name> (<year>2024</year>). <italic toggle="yes">Free Statistics Calculators</italic>: Version 4.0. Retrieved from: <uri xlink:href="https://www.danielsoper.com/statcalc/calculator.aspx?id=48">https://www.danielsoper.com/statcalc/calculator.aspx?id=48</uri>.</mixed-citation></ref><ref id="r900"><mixed-citation publication-type="other" id="ref900"><string-name><surname>Sterne</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Savovi&#x00107;</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Page</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Elbers</surname>, <given-names>R.G.</given-names></string-name>, <string-name><surname>Blencowe</surname>, <given-names>N.S.</given-names></string-name>, <string-name><surname>Boutron</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Cates</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>H.Y.</given-names></string-name>, <string-name><surname>Corbett</surname>, <given-names>M.S.</given-names></string-name>, <string-name><surname>Eldridge</surname>, <given-names>S.M.</given-names></string-name> &#x00026; <string-name><surname>Emberson</surname>, <given-names>J.R.</given-names></string-name> (<year>2019</year>). RoB 2: a revised tool for assessing risk of bias in randomised trials. <italic toggle="yes">bmj</italic>, 366.</mixed-citation></ref><ref id="r52"><mixed-citation publication-type="journal" id="ref52"><string-name><surname>Turkington</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kingdon</surname>, <given-names>D.</given-names></string-name>, &#x00026; <string-name><surname>Turner</surname>, <given-names>T.</given-names></string-name> (<year>2002</year>). <article-title>Effectiveness of a brief cognitive&#x02013;behavioural therapy intervention in the treatment of schizophrenia</article-title>. <source>The British Journal of Psychiatry</source>, <volume>180</volume>(<issue>6</issue>), <fpage>523</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">12042231</pub-id>
</mixed-citation></ref><ref id="r43"><mixed-citation publication-type="journal" id="ref43"><string-name><surname>Valentine</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Pigott</surname>, <given-names>T. D.</given-names></string-name>, &#x00026; <string-name><surname>Rothstein</surname>, <given-names>H. R.</given-names></string-name> (<year>2010</year>). <article-title>How many studies do you need? A primer on statistical power for meta-analysis</article-title>. <source>Journal of Educational and Behavioral Statistics</source>, <volume>35</volume>(<issue>2</issue>), <fpage>215</fpage>&#x02013;<lpage>247</lpage>.</mixed-citation></ref><ref id="r44"><mixed-citation publication-type="book" id="ref44"><string-name><surname>van de Ven</surname>, <given-names>M. P.</given-names></string-name>, <string-name><surname>van den Berg</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Schuurmans</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>van der Vleugel</surname>, <given-names>B. M.</given-names></string-name>, <string-name><surname>van Zelst</surname>, <given-names>C. J.</given-names></string-name>, &#x00026; <string-name><surname>Staring</surname>, <given-names>A. B.</given-names></string-name> (<year>2025</year>). <source>The availability of Cognitive Behaviour Therapy for psychosis (CBTp) inThe Netherlands</source>. <publisher-name>Psychosis</publisher-name>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="r46"><mixed-citation publication-type="journal" id="ref46"><string-name><surname>Wakefield</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kellett</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Simmonds-Buckley</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Stockton</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bradbury</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Delgadillo</surname>, <given-names>J.</given-names></string-name> (<year>2021</year>). <article-title>Improving Access to Psychological Therapies (IAPT) in the United Kingdom: A systematic review and meta-analysis of 10-years of practice-based evidence</article-title>. <source>British Journal of Clinical Psychology</source>, <volume>60</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">32578231</pub-id>
</mixed-citation></ref><ref id="r48"><mixed-citation publication-type="other" id="ref48"><collab>World Health Organization</collab>. (<year>2022</year>). <italic toggle="yes">Schizophrenia.</italic> Retrieved from: <uri xlink:href="https://www.who.int/news-room/fact-sheets/detail/schizophrenia">https://www.who.int/news-room/fact-sheets/detail/schizophrenia</uri>.</mixed-citation></ref><ref id="r49"><mixed-citation publication-type="journal" id="ref49"><string-name><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, &#x00026; <string-name><surname>Parmanto</surname>, <given-names>B.</given-names></string-name> (<year>2019</year>). <article-title>Reaching people with disabilities in underserved areas through digital interventions: Systematic review</article-title>. <source>Journal of Medical Internet Research</source>, <volume>21</volume>(<issue>10</issue>), <fpage>e12981</fpage>.<pub-id pub-id-type="pmid">31654569</pub-id>
</mixed-citation></ref></ref-list></back></article>